Midjourney, the San Francisco-based AI company best known for text-to-image generation, has made a dramatic pivot into medical hardware with a new full-body ultrasound scanner.
The company launched its medical division on June 18, 2026, unveiling the Midjourney Scanner, a device it claims will eventually complete a full internal body scan in just 60 seconds.
The scanner works by lowering users through a ring of half a million underwater ultrasonic sensors that fire sound waves through the body from every angle simultaneously.
Thousands of computers then reconstruct how those waves shift at each tissue boundary, producing what Midjourney describes as a full three-dimensional anatomical model.
Midjourney says the result is “a 3D map of your body, down to a fraction of a millimeter, that looks a lot like today’s MRIs but at nearly a hundred times the speed.”
The company is developing the machine in partnership with handheld ultrasound device maker Butterfly Network (BFLY), having signed a licensing agreement in November 2025 to secure exclusive rights to its ultrasound-on-chip technology.
However, the current prototype is far from the finished product its promotional language suggests, with each scan currently taking roughly 20 minutes to complete.
The device has so far been used on approximately a dozen people, runs without any AI in its imaging pipeline, and carries no FDA clearance for diagnosing any medical condition.
The advertised 60-second scan time remains a goal rather than a reality, with engineers still bottlenecked by data transfer speeds between the transducers and the reconstruction computing cluster.
The central question for anyone evaluating this project is not whether the underlying physics work, but whether a nine-person team with no experience in regulated medical devices can close that gap.
Midjourney plans to make its scanning technology the centerpiece of a new spa it intends to open in downtown San Francisco before the end of next year.
The company’s roadmap targets a second-generation hardware design within the next 12 months, followed by a third-generation scanner built on fully custom silicon by 2028.
That third-generation device would move away from Butterfly Network’s licensed chip technology entirely, using silicon designed from scratch by Midjourney’s own engineering team.
The long-term commercial ambition is striking, with the company targeting a fleet of 50,000 scanners worldwide by 2031, capable of processing 1 billion scans per month.
None of the performance figures or commercialization plans presented by Midjourney have been verified in actual medical settings, and the company will need to navigate clinical trials and regulatory review before any diagnostic use can be certified.
